Carregant...

Level of adherence and HIV RNA suppression in the current era of Highly Active Antiretroviral Therapy (HAART)

The need to achieve ≥95% adherence to HAART for treatment effectiveness may be a barrier for universal initiation at early stages of HIV. Using longitudinal data collected from 2006-2011 from cohort studies of MSM (MACS) and IDUs (ALIVE study), we estimated the minimum adherence needed to achieve HI...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:AIDS Behav
Autors principals: Viswanathan, Shilpa, Detels, Roger, Mehta, Shruti H., Macatangay, Bernard J.C., Kirk, Gregory D., Jacobson, Lisa P.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4393774/
https://ncbi.nlm.nih.gov/pubmed/25342151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10461-014-0927-4
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!